The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Figure 1.17

CSR Figure 1.17: SEER Incidence, Burden vs Risk by Cancer Site


Figure 1.17

Incidence Percent Change between 2007 and 2016
Numbers (burden) vs Rates (risk)
All Races, All Ages, Both Sexes

Cancer Site Burden Percent ChangeRisk Percent Change
Thyroid 33.1 20.2
Liver & IBD 40.4 12.5
Corpus & Uterus, NOS 33.0 11.4
Melanoma of the Skin 29.5 9.6
Myeloma 34.0 9.5
Oral Cavity & Pharynx 26.3 4.6
Testis 9.0 3.4
Pancreas 24.9 1.9
Kidney & Renal Pelvis 22.1 1.7
Breast (Female) 15.5 -0.1
Leukemia 14.1 -2.8
Non-Hodgkin Lymphoma 10.1 -7.5
Cervix Uteri -1.5 -8.7
Stomach 7.3 -11.0
All Cancer Sites 7.0 -11.2
Brain & ONS 1.6 -11.6
Esophagus 9.2 -11.7
Hodgkin Lymphoma -5.5 -13.5
Urinary Bladder 4.6 -14.3
Ovarya -6.5 -18.8
Lung & Bronchus -0.5 -19.5
Colon & Rectum -5.8 -21.5
Larynx -4.0 -21.8
Prostate -17.2 -37.0

Footnotes:

Source: SEER 21 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey, Georgia excluding ATL/RG, Idaho, New York and Massachusetts).

Burden is the change in the number of incidence cases between 2007 and 2016.

Risk is the change in the cancer incidence rates between 2007 and 2016.

aOvary excludes borderline cases or histologies 8442, 8451, 8462, 8472, and 8473.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.